53ment of vestibular schwannoma. Neurosurgery.
2012;70(2):334–40. discussion 40–1- Slattery WH 3rd, Brackmann DE, Hitselberger
W. Middle fossa approach for hearing preserva-
tion with acoustic neuromas. Am J Otolaryngol.
1997;18(5):596–601. - Woodson EA, Dempewolf RD, Gubbels SP, Porter
AT, Oleson JJ, Hansen MR, et al. Long-term hearing
preservation after microsurgical excision of vestibular
schwannoma. Otol Neurotol. 2010;31(7):1144–52. - Gurgel RK, Theodosopoulos PV, Jackler
RK. Subtotal/near-total treatment of vestibular
schwannomas. Curr Opin Otolaryngol Head Neck
Surg. 2012;20(5):380–4. - Monfared A, Corrales E, Theodosopoulos P, Blevins
NH, Oghalai JS, Selesnick SH, et al. Facial nerve
outcome and tumor control rate as a function of
degree of resection in treatment of large acous-
tic neuromas: preliminary report of the acoustic
neuroma subtotal resection study. Neurosurgery.
2015;79(2):194–203. - Gurgel RK, Dogru S, Amdur RL, Monfared
A. Facial nerve outcomes after surgery for large
vestibular schwannomas: do surgical approach
and extent of resection matter? Neurosurg Focus.
2012;33(3):E16. - Rodgers GK, Luxford WM. Factors affecting the
development of cerebrospinal fluid leak and menin-
gitis after translabyrinthine acoustic tumor surgery.
Laryngoscope. 1993;103(9):959–62. - Hillman TA, Shelton C. Resorbable plate cranioplasty
after the translabyrinthine approach. Otol Neurotol.
2011;32(7):1171–4. - Nimjee SM, Powers CJ, Kolls BJ, Smith T, Britz GW,
Zomorodi AR. Endovascular treatment of venous
sinus thrombosis: a case report and review of the lit-
erature. J Neurointerv Surg. 2011;3(1):30–3. - Ohata K, Haque M, Morino M, Nagai K, Nishio A,
Nishijima Y, et al. Occlusion of the sigmoid sinus after
surgery via the presigmoidal-transpetrosal approach.
J Neurosurg. 1998;89(4):575–84. - Medel R, Monteith SJ, Crowley RW, Dumont AS. A
review of therapeutic strategies for the management
of cerebral venous sinus thrombosis. Neurosurg
Focus. 2009;27(5):E6. - Wasay M, Kojan S, Dai AI, Bobustuc G, Sheikh
Z. Headache in cerebral venous thrombosis: inci-
dence, pattern and location in 200 consecutive
patients. J Headache Pain. 2010;11(2):137–9. - Keiper GL Jr, Sherman JD, Tomsick TA, Tew JM
Jr. Dural sinus thrombosis and pseudotumor cerebri:
unexpected complications of suboccipital craniotomy
and translabyrinthine craniectomy. J Neurosurg.
1999;91(2):192–7. - Moore J, Thomas P, Cousins V, Rosenfeld
JV. Diagnosis and management of dural sinus
thrombosis following resection of cerebellopontine
angle tumors. J Neurol Surg B Skull Base. 2014;
75(6):402–8.
63. Coutinho JM, de Bruijn SF, de Veber G, Stam
J. Anticoagulation for cerebral venous sinus thrombo-
sis. Stroke. 2012;43(4):e41–e2.
64. Kimmell KT, Jahromi BS. Clinical factors associated
with venous thromboembolism risk in patients under-
going craniotomy. J Neurosurg. 2015;122(5):1004–11.
65. Agnelli G, Piovella F, Buoncristiani P, Severi P,
Pini M, D’Angelo A, et al. Enoxaparin plus com-
pression stockings compared with compression
stockings alone in the prevention of venous thrombo-
embolism after elective neurosurgery. N Engl J Med.
1998;339(2):80–5.
66. Bostrom S, Holmgren E, Jonsson O, Lindberg S,
Lindstrom B, Winso I, et al. Post-operative throm-
boembolism in neurosurgery. A study on the prophy-
lactic effect of calf muscle stimulation plus dextran
compared to low-dose heparin. Acta Neurochir.
1986;80(3–4):83–9.
67. Cerrato D, Ariano C, Fiacchino F. Deep vein throm-
bosis and low-dose heparin prophylaxis in neurosur-
gical patients. J Neurosurg. 1978;49(3):378–81.
68. Collen JF, Jackson JL, Shorr AF, Moores
LK. Prevention of venous thromboembolism in neuro-
surgery: a metaanalysis. Chest. 2008;134(2):237–49.
69. Dickinson LD, Miller LD, Patel CP, Gupta
SK. Enoxaparin increases the incidence of post-
operative intracranial hemorrhage when initiated
preoperatively for deep venous thrombosis prophy-
laxis in patients with brain tumors. Neurosurgery.
1998;43(5):1074–81.
70. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park
JK, Black PM. Low rate of venous thromboembolism
after craniotomy for brain tumor using multimodality
prophylaxis. Chest. 2002;122(6):1933–7.
71. Macdonald RL, Amidei C, Baron J, Weir B, Brown
F, Erickson RK, et al. Randomized, pilot study of
intermittent pneumatic compression devices plus
dalteparin versus intermittent pneumatic compression
devices plus heparin for prevention of venous throm-
boembolism in patients undergoing craniotomy. Surg
Neurol. 2003;59(5):363–72. discussion 72–4
72. Nurmohamed MT, van Riel AM, Henkens CM,
Koopman MM, Que GT, d’Azemar P, et al. Low
molecular weight heparin and compression stockings
in the prevention of venous thromboembolism in neu-
rosurgery. Thromb Haemost. 1996;75(2):233–8.
73. Hamilton MG, Yee WH, Hull RD, Ghali WA. Venous
thromboembolism prophylaxis in patients undergoing
cranial neurosurgery: a systematic review and meta-
analysis. Neurosurgery. 2011;68(3):571–81.
74. Gould MK, Garcia DA, Wren SM, Karanicolas PJ,
Arcelus JI, Heit JA, et al. Prevention of VTE in nonor-
thopedic surgical patients: antithrombotic therapy and
prevention of thrombosis, 9th ed: American College
of chest physicians evidence-based clinical practice
guidelines. Chest. 2012;141(2 Suppl):e227S–77S.
75. Brackmann DE, Shelton C, Arriaga MA, Pazos A,
Illustrator. In: Otologic surgery, 2nd ed. Philadelphia:
W.B. Saunders Company; 2001.
3 Middle Fossa and Translabyrinthine Approaches